Glenmark Pharma in agreement with Pfizer for Axitinib tabs, 1 mg and 5 mg
The Inlyta tablets, 1 mg and 5 mg market 2 achieved annual sales of approximately $644.5 million
Axitino | 22/11/2022 | By Sudeep Soparkar | 464
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy